Indefinite Delivery Contract 36E79726D0002
- Not listed
- This Indefinite Delivery Contract (IDC) SPE2D223D0008 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Avkare LLC, a pharmaceutical and medical supply company based in Pulaski, Tennessee. The $34.27 million contract is for the distribution of metformin HCL ER tablets in various bottle counts and dosages to the Department of Defense (DoD), Department of Veterans Affairs (VA), Indian Health Service (IHS), and Bureau of Prisons. The contract has a one-year base period with...
- Avkare LLC was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center on December 23, 2023, to supply Teriflunomide tablets to multiple federal healthcare agencies. The contract has a total ceiling value of $995,714.50 and covers a base period from December 23, 2023, through December 22, 2024, with four one-year option periods extending the ultimate completion date to December 22, 2026. The contract is not subject to small business...
- Avkare LLC was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center on June 23, 2025, with a ceiling value of $24.9 million and a period of performance from June 23, 2025, through June 22, 2026. The contract procures Mycophenolate Mofetil capsules and tablets, an immunosuppressant medication commonly used in organ transplantation and treatment of autoimmune conditions. The procurement is unrestricted with no small business...
- Avkare LLC was awarded a multiple-award Indefinite Delivery Contract on January 30, 2024, by the Department of Veterans Affairs National Acquisition Center to provide an uninterrupted supply of Valganciclovir HCL tablets. The contract has a ceiling value of $7.97 million with a base period of one year and four one-year option periods, extending through January 29, 2026. This civilian agency procurement was issued without small business set-aside restrictions, allowing Avkare to compete on an...
- Avkare LLC was awarded a single-award Indefinite Delivery Contract (IDC) by the Department of Veterans Affairs National Acquisition Center on October 6, 2025, valued at approximately $9.98 million through October 5, 2026. The contract covers the supply of Emtricitabine 200mg/Tenofovir Disoproxil Fumarate 300mg tablets, antiretroviral medications commonly used in HIV treatment regimens. The base ordering period runs one year with four one-year option periods, enabling a potential five-year...
- Avkare LLC was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center on June 17, 2025, with a ceiling value of $20.31 million to supply Abiraterone Acetate 250 milligram tablets. The contract structure includes a one-year base period with four one-year option periods, extending through June 16, 2026. This procurement is unrestricted with no small business set-aside designation, and the contract will support multiple federal...
- The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract to Avkare, LLC on February 23, 2019. The contract has a potential value of $2.29M and a period of performance from February 23, 2019 through February 22, 2024, consisting of a base year and four option years. Under the contract, Avkare will supply tenofovir disoproxil fumarate tablets to the VA, Department of Defense, Bureau of Prisons, and Indian Health Service through their...
- This federal contract IDV award to Avkare, LLC is for the provision of pharmaceutical and medical supply products to the Department of Veterans Affairs (VA), Department of Defense (DoD), Indian Health Service (IHS), and Bureau of Prisons. The single-award Indefinite Delivery Contract has a ceiling value of $1,244,773.20 and a period of performance from the award date of July 15, 2024 through July 14, 2026, with four one-year option periods. The solicitation, which will be issued electronically...
- Avkare LLC was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center on July 31, 2022, for the supply of Acetazolamide tablets. This civilian agency contract, valued at $2.08 million with no small business set-aside, establishes a framework for the delivery of this carbonic anhydrase inhibitor medication, which is utilized in federal healthcare systems for various therapeutic applications including treatment of altitude sickness,...
- The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract to Avkare, LLC, a for-profit limited liability company, to provide abiraterone tablets. This 1-year base contract with four 1-year option periods has a potential value of $70,208,375.13. The contract will supply the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS) with an uninterrupted source of abiraterone acetate 250mg tablets, with an...
Avkare LLC has been awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center for the supply of Metformin Hydrochloride 24-hour sustained-release tablets in 500mg and 750mg strengths. The contract, effective December 30, 2025, through December 29, 2026, with four one-year option periods, carries a ceiling value of $90.7 million and will serve as a source for multiple federal healthcare agencies including the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The pharmaceutical products will be distributed through established VA and Department of Defense Pharmaceutical Prime Vendor Programs, with estimated annual requirements exceeding 1.1 million bottles across nine line items featuring various bottle configurations ranging from 30-count to 1,000-count units. Avkare must provide products under its own unique National Drug Code labeling with safety-caps and deshelling capability, packaged in bottles meeting specified volume and circumference requirements compatible with federal labeling standards. The original solicitation (36E79725R0051), issued under unrestricted commercial item procurement procedures without set-aside designations, was posted June 23, 2025, with proposals due July 28, 2025. This procurement represents a continuation of federal pharmaceutical supply strategy to ensure consistent availability of generic metformin formulations across the VA healthcare system and affiliated federal agencies. The contract structure includes a base year plus four pre-priced option periods, allowing federal agencies to issue delivery orders as operational needs dictate. As a for-profit limited liability company registered in the System for Award Management since 2007, Avkare brings established expertise in pharmaceutical distribution to federal healthcare organizations, with a demonstrated track record of managing large-volume pharmaceutical supply contracts exceeding $1.6 billion in aggregate federal business.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Add Subcontract Plan | $0 | 12/10/25 | |
| Not listed | Not listed | $0 | 10/30/25 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6505--Metformin SA Tablets | 36E79725R0051 | Department of Veterans Affairs National Acquisition Center | Award Notice 3/3 | 12/8/25, 3:31 PM | |
6505--Metformin 24HR SA Tablets PPV | 36E79725R0051 | Department of Veterans Affairs National Acquisition Center | Pre-Solicitation 1/3 | 6/23/25, 8:11 AM | |
6505--Metformin 24HR SA Tablets PPV | 36E79725R0051 | Department of Veterans Affairs National Acquisition Center | Solicitation 2/3 | 7/9/25, 10:19 AM |